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Neuroligins are postsynaptic cell-adhesion mole-
cules that interact with presynaptic neurexins. Rare
mutations in neuroligins and neurexins predispose
to autism, including a neuroligin-3 amino acid substi-
tution (R451C) and a neuroligin-3 deletion. Previous
analyses showed that neuroligin-3 R451C-knockin
mice exhibit robust synaptic phenotypes but failed
to uncover major changes in neuroligin-3 knockout
mice, questioning the notion that a common synaptic
mechanism mediates autism pathogenesis in pa-
tients with these mutations. Here, we used paired
recordings in mice carrying these mutations to mea-
sure synaptic transmission at GABAergic synapses
formed by hippocampal parvalbumin- and cholecys-
tokinin-expressing basket cells onto pyramidal neu-
rons. We demonstrate that in addition to unique
gain-of-function effects produced by the neuroligin-
3 R451C-knockin but not the neuroligin-3 knockout
mutation, bothmutations dramatically impaired tonic
but not phasic endocannabinoid signaling. Our data
thus suggest that neuroligin-3 is specifically required
for tonic endocannabinoid signaling, raising the pos-
sibility that alterations in endocannabinoid signaling
may contribute to autism pathophysiology.
INTRODUCTION
Neuroligins are postsynaptic cell-adhesion molecules that are
expressed in four principal isoforms (neuroligin-1 to -4, abbrevi-
ated as NL1 to NL4), and that act as ligands for presynaptic neu-
rexins (Ichtchenko et al., 1995; 1996). NL1 is found in excitatory
synapses (Song et al., 1999), NL2 in inhibitory synapses (Varo-
queaux et al., 2004; Graf et al., 2004), NL3 in both (Budreck
and Scheiffele, 2007), and NL4 in glycinergic synapses (Hoon
et al., 2011). In humans, more than 30 neuroligin gene mutations
have been associated with autism, including a NL3 point muta-
tion (the R451C substitution; Jamain et al., 2003) and a NL3 dele-
tion (Sanders et al., 2011).
Experiments with knockout (KO) mice revealed that neuroli-
gins are essential for synaptic transmission and suggest that498 Neuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc.neuroligins organize synapses and determine synapse proper-
ties (Varoqueaux et al., 2006). Specifically, triple KOmice lacking
NL1, NL2, and NL3 die at birth because their synapses—
although morphologically normal—exhibit severe impairments
in synaptic transmission (Varoqueaux et al., 2006). Moreover,
single KO mice lacking either NL1 or NL2 exhibit major deficits
in excitatory or inhibitory synaptic transmission, respectively
(Chubykin et al., 2007; Gibson et al., 2009; Poulopoulos et al.,
2009). NL3 KOmice display changes in spontaneous ‘‘mini’’ syn-
aptic events in the hippocampus (Tabuchi et al., 2007; Etherton
et al., 2011a) and in mGluR5 signaling in the cerebellum (Bau-
douin et al., 2012). Together, these findings are consistent with
the notion that neuroligins specify synaptic properties instead
of functioning as general ‘‘glues’’ for synapses (Varoqueaux
et al., 2006). These conclusions are additionally supported by
characterization of another NL3 mutation, the R704C substitu-
tion (Etherton et al., 2011b). The R704C substitution corre-
sponds to an autism-associated mutation in NL4 that, when
introduced into NL3, selectively altered postsynaptic AMPA-
type glutamate receptor levels, confirming that neuroligins
contribute to shaping synapse properties.
In contrast to NL3 KOmice, NL3 knockin (KI) mice carrying the
R451C substitution (that mimics a human autism mutation
similar to the NL3 KO) displayed robust synaptic phenotypes,
which differed between the somatosensory cortex and hippo-
campus and were absent from NL3 KO mice (Tabuchi et al.,
2007; Etherton et al., 2011a; see also Su¨dhof, 2008). Although
different behavioral phenotypes were reported for two indepen-
dently generated R451C KI mouse lines (Tabuchi et al., 2007;
Chadman et al., 2008), both mouse lines exhibited the same re-
gion-specific changes in synaptic function (Etherton et al.,
2011a). These changes in NL3 R451C-mutant mice were largely
due to gain-of-function mechanisms because the NL3 KO syn-
apses did not exhibit the same changes, even though the
R451C substitution destabilizes NL3 (De Jaco et al., 2010) and
caused a loss of more than 90% of NL3 protein in vivo (Tabuchi
et al., 2007). Because both the inactivation and the R451C
substitution of NL3 are implicated in autism, it seems likely
that the gain-of-function changes, as opposed to the loss-of-
function changes, may not be relevant for understanding
autism. However, to date, no synaptic phenotype was detected
that is shared by the two known autism-associated NL3 muta-
tions, raising the question of how these mutations may actually
induce autism.
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contribute to autism pathogenesis, we here followed up on the
observation that the NL3 KO increases inhibitory and decreases
excitatory spontaneous mini events in the hippocampus (Ether-
ton et al., 2011a). Since the NL3 KO did not alter evoked excit-
atory synaptic strength in the hippocampus, we hypothesized
that the NL3 KO may cause a specific change in a subset of
inhibitory synapses. The hippocampus containsmultiple, at least
21, different types of inhibitory neurons that exhibit specific cir-
cuit properties (Klausberger and Somogyi, 2008). Thus, when
examining inhibitory synaptic transmission, it is advantageous
to investigate specific synapses formed by identified types of
inhibitory neurons. To this end, we performed paired recordings
that monitor synapses formed by two different defined types of
inhibitory basket cells onto the soma and proximal dendrites of
pyramidal neurons. One type of basket cell coexpresses presyn-
aptic cannabinoid type-1 (CB1) receptors and the neuropeptide
cholecystokinin (CCK; ‘‘CCK basket cells’’), whereas the other
type expresses parvalbumin (PV; ‘‘PV basket cells’’; Freund,
2003; Freund et al., 2003; Bartos et al., 2007; Klausberger and
Somogyi, 2008). The two types of basket cells participate in par-
allel inhibitory systems that play distinct but complementary
roles in network oscillations (Bartos et al., 2007; Klausberger
et al., 2005) and have been implicated in neurological and
mood disorders (Freund and Katona, 2007; Lisman et al.,
2008). In these paired recordings, we sought to identify specific
loss-of-function effects that are shared by both the NL3 KO and
the R451C KI mutation since both are associated with autism,
prompting us to analyze both mutations in parallel.
Our data show that NL3 R451C KI and NL3 KO neurons exhibit
distinct phenotypes at synapses formed by PV basket cells,
similar to previous observations in other synapses (Tabuchi
et al., 2007; Etherton et al., 2011a). Surprisingly, however, we
find that at synapses formed by CCK basket cells, the two
mutations produced the same phenotype that consisted of a
loss of the tonic CB1 receptor-dependent suppression of
GABA release that is observed at these synapses (Losonczy
et al., 2004; Hentges et al., 2005; Neu et al., 2007; Ali and
Todorova, 2010; Kim and Alger, 2010). This observation iden-
tifies NL3 as the first molecule that is selectively essential for
tonic endocannabinoid signaling, an enigmatic component of
overall endocannabinoid signaling (Alger, 2012). Given the
common genetic association of the R451C substitution and
NL3 deletion with autism, our data thus suggest that disrupted
endocannabinoid signalingmay contribute to autism pathophys-
iology, a tantalizing idea given the great interest in developing
therapeutic approaches that modify endocannabinoid signaling
in the brain.
RESULTS
R451C KI Impairs GABAergic Synaptic Transmission at
PV Basket Cell Synapses
We performed paired whole-cell recordings between presynap-
tic basket cells and postsynaptic CA1 pyramidal neurons in
acute slices from littermate wild-type and R451C KI mice (Tabu-
chi et al., 2007). In these recordings, we determined the charac-
teristics of synaptic transmission by measuring unitary inhibitorypost-synaptic currents (IPSCs) evoked by basket cell action po-
tentials (APs) (see Experimental Procedures for details).
We found that the R451C KI severely impaired synaptic trans-
mission at synapses formed by PV basket cells onto pyramidal
neurons (Figures 1A and 1B). The amplitude of IPSCs was
decreased by 70% (failures included), and the success rate
with which an AP elicited an IPSC was lowered by 20%. This
phenotype was observed independent of whether APs were
induced at 1 Hz, 2 Hz, or 10 Hz. In addition, we observed a statis-
tically insignificant decrease in IPSC half-widths (Figure 1C; WT:
5 ± 0.3 ms, R451C: 4.3 ± 0.2 ms). The impairment of IPSCs in
R451C KI neurons was independent of postsynaptic membrane
potential (analyzed from 80 to +60 mV; Figure 1E and see Fig-
ure S1 available online), and the R451C KI did not affect the
reversal potential of PV basket cell-evoked IPSCs (WT: 18.6 ±
1.9 mV, R451C: 19.4 ± 2.1 mV). Moreover, we observed no
change in the amplitude of the minimal unitary IPSC that could
be evoked by a presynaptic AP, suggesting that single synaptic
events elicited similar postsynaptic responses (Figure 1D; WT:
22.5 ± 3.5 pA, R451C: 16.4 ± 0.8 pA). We also found no change
in the number of trials needed to identify synaptically connected
pairs of PV basket cell/pyramidal neurons, indicating that the
number of pyramidal neurons innervated by individual PV basket
cells was not altered (Figure 1F; WT: 1.8 ± 0.3, R451C: 1.8 ± 0.2
trials per presynaptic basket cell). Finally, we did not detect
major morphological changes in the axonal or dendritic arbor of
PV basket cells in R451C KI mice (Figure 1G).
Together, these data show that the R451C KI produces a large
impairment in synaptic transmission at synapses formed by PV
basket cells onto pyramidal neurons. The lack of a change in
the voltage-dependence of IPSCs, the reversal potential, and
the minimal unitary IPSC size suggest that the R451C KI did
not alter the number of postsynaptic GABA receptors or disrupt
postsynaptic chloride homeostasis, while the lack of change in
the IPSC kinetics suggests that the subunit composition of
GABA-receptors or the reuptake kinetics of released GABA
were not altered significantly. The decrease in the success rate
of eliciting an IPSC from PV basket cells suggests that the
R451C KI impaired synaptic transmission by a presynaptic
mechanism, despite the presumed postsynaptic localization of
NL3. Notably, this is the first phenotype of the R451C mutation
that entails a decrease in synaptic strength, not an increase as
previously observed for global inhibitory synaptic transmission
in the somatosensory cortex (Tabuchi et al., 2007) and for both
AMPA- and NMDA-receptor-mediated excitatory synaptic
transmission in the hippocampus (Etherton et al., 2011a).
The R451C KI Enhances GABAergic Synaptic
Transmission at CCK Basket Cell Synapses
We next analyzed the properties of transmission at pyramidal
synapses formed by CCK basket cells. Surprisingly, here the
R451C KI caused an 100% increase in the IPSC amplitudes
and an 15% increase in the IPSC success rate during 1 Hz
stimulation and a slightly smaller change during 2 and 10 Hz
stimulation (Figures 2A and 2B). The increase in success rate
suggests an increase in the presynaptic GABA release probabil-
ity, which is also a plausible explanation for the increase in IPSC
amplitudes. This hypothesis was further supported by theNeuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc. 499
Figure 2. Neuroligin-3 R451C Substitution Enhances GABAergic
Synaptic Transmission in CCK Basket Cell Synapses
(A) Paired recordings of presynaptic APs in CCK basket cells (upper traces)
that produce unitary IPSCs in CA1 pyramidal cells (lower traces, Vholding =
70 mV).
(B) Comparison of IPSC amplitudes (including failures) and of the percentages
of successful transmissions induced by presynaptic APs applied at 1, 5, and
10 Hz in wild-type and R451C mutant synapses. Open circles represent indi-
vidual pairs (nWT = 8, nR451C = 17, Mann-Whitney RST, p = 0.013 at 1 Hz IPSCs,
and p > 0.08 in all other data sets). Mean ± SEM.
(C and D) No change in IPSC half width (nWT = 8, nR451C = 15, Mann-Whitney
RST, p = 0.098) and no increase in the minimal IPSC amplitudes in R451C KI
(nWT = 8, nR451C = 15, Mann-Whitney RST, p = 0.5) suggest that the enhanced
IPSC amplitudes in R451C KIs is not due to changes in quantal GABA receptor
responses. Mean ± SEM.
(E) The frequency of finding synaptically coupled pairs was not altered in
R451C mice. Mean ± SEM.
(F) Neurolucida reconstructions of biocytin-filled basket cells show no major
reorganization in axonal and dendritic arbor of CCK basket cells.
Figure 1. Neuroligin-3 R451C Substitution Impairs GABAergic
Synaptic Transmission in PV Basket Cell Synapses
(A) Paired recordings of presynaptic APs in PV basket cells (upper traces) that
produce unitary IPSCs in CA1 pyramidal cells (lower traces, Vholding =70mV).
(B) Comparison of IPSC amplitudes (including failures) and of the percentages
of successful transmissions induced by presynaptic APs applied at 1, 5, and
10 Hz in wild-type and R451C mutant synapses. Open circles represent indi-
vidual pairs (nWT = 14, nR451C = 27, Mann-Whitney RST, p < 0.02 for all data
sets). Mean ± SEM.
(C) The R451C KI mutation did not alter the half width of IPSCs (nWT = 14,
nR451C = 23, Mann-Whitney RST, p = 0.092). Mean ± SEM.
(D) Quantification of minimal IPSCs (amplitude of reliably occurring smallest
IPSCs in each pair) suggest no change in quantal response in the R451C KI
(nWT = 15, nR451C = 25, Mann-Whitney RST, p = 0.235). Mean ± SEM.
(E) Additional paired-recordings show that IPSCs was independent of post-
synaptic membrane voltage in R451C KI mice (nWT = 3, nR451C = 4).
Mean ± SEM.
(F) The frequency of finding synaptically coupled pairs was not altered in
R451C mice. Mean ± SEM.
(G) Neurolucida reconstructions of biocytin-filled basket cells show major
reorganization in axonal and dendritic arbor of PV basket cells (str. = stratum,
pyr. = pyramidale, rad. = radiatum).
See also Figure S1.
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500 Neuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc.absence of detectable changes in the IPSC half-width, indicating
that the GABA-receptor subunit composition or uptake mecha-
nisms were unaltered (Figure 2C; WT: 6.3 ± 0.4 ms, R451C:
Figure 3. Neuroligin-3 KO Does Not Alter GABAergic Transmission
in PV Basket Cell Synapses
(A and B) Paired-recording data show that IPSC amplitudes and transmission
rates were unaltered in NL3 KO mice compared to WT littermates (nWT = 12,
nKO = 8, Mann-Whitney RST, p > 0.32 in all data sets). (B) Mean ± SEM.
(CandD)Quantificationof IPSChalfwidthandminimal IPSCamplitudessuggest
no changes in postsynaptic GABA receptor subunit composition. Mean ± SEM.
(E) The frequency of finding connected pairs was similar in NL3 WT and KO
mice. Mean ± SEM.
Figure 4. Neuroligin-3 KO Enhances GABAergic Synaptic Transmis-
sion in CCK Basket Cell Synapses Similar to the R451C KI
(A and B) Paired recording data show that IPSC amplitudes and transmission
rates were enhanced in CCK basket cell to CA1 pyramidal neuron synapses at
multiple AP firing frequencies (nWT = 28, nKO = 36,Mann-Whitney RST, p = 0.12
at 10 Hz IPSCs, and p < 0.03 for all other data set). (B) Mean ± SEM.
(C) Increase in IPSC half width in KO suggest possible subunit reorganization
of GABA receptor subunits in NL3 KO (nWT = 28, nKO = 35, Mann-Whitney RST,
p = 0.021). Mean ± SEM.
(D and E) No change in minimal IPSC amplitudes (nWT = 28, nKO = 35, Mann-
Whitney RST, p = 0.885), and in the frequency of finding connected pairs
between CCK basket cells and pyramidal cells. Mean ± SEM.
Neuron
Neuroligin-3 in Tonic Endocannabinoid Signaling5.4 ± 0.3 ms). Furthermore, the amplitude of minimal unitary
IPSCs (Figure 2D; WT: 23.4 ± 4.3 pA, R451C: 29.6 ± 4 pA) and
the rate of finding connected pairs (Figure 2E; WT: 2.6 ± 0.7,
R451C: 2.2 ± 0.3) were similar in wild-type andR451Cmutant sli-
ces, as was themorphology of their CCK basket cells (Figure 2F).
The phenotype of the R451C mutation in the CCK cell synapses
again was more consistent with a presynaptic change (such as
increased release probability) than a structural alteration (e.g., in-
crease in synapse density) or postsynaptic effect. Thus, the
R451C KI produces opposite changes at two different periso-
matic inhibitory synapses, and in both cases the changes appear
to involve an ultimately presynaptic mechanism, even though
NL3 is a postsynaptic molecule.
A Synaptic Phenotype of NL3 KO Mice
To test whether the R451C KI phenotypes represent gain- or
loss-of-function effects, we next performed paired recordings
in acute slices from NL3 KO mice, again using littermate wild-
typemice as controls. Whenwe analyzed the properties of trans-
mission between PV basket cells and pyramidal neurons, wefailed to detect a phenotype. Specifically, the amplitude and suc-
cess rate of IPSCs were unchanged (Figures 3A and 3B), as were
the half-width of the IPSCs (Figure 3C;WT: 4.7 ± 0.2ms, NL3 KO:
5.5 ± 0.4 ms), the size of unitary minimal IPSCs (Figure 3D;
WT: 17.6 ± 1.6 pA, NL3 KO: 16.5 ± 1.1 pA) and the rate of finding
connected pairs (Figure 3E; WT: 2.2 ± 0.3, NL3 KO: 2.5 ± 0.6).
These results suggest that the loss of synaptic transmission at
this synapse in R451C mutant mice represents an active sup-
pression of synaptic transmission by a gain-of-function activity
of R451C mutant NL3.
We then examined the effect of the NL3 KO on synaptic trans-
mission mediated by inhibitory synapses that were formed by
CCK-containing terminals on pyramidal neurons (Figure 4). Sur-
prisingly, here the NL3 KO phenocopied the R451C KI. Specif-
ically, the NL3 KO caused a significant increase in synaptic
strength, as manifested by both an increase in IPSC amplitudeNeuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc. 501
Figure 5. The NL3 R451C KI Mutation Lowers the Probability of GABA Release from PV Basket Cell Synapses
(A) Averaged PV basket cell IPSCs (same data as in Figure 1) are plotted against their corresponding averaged success rates (WT data were pooled from wild-type
littermates of R451CKI and NL3 KOmice). Data were fitted to the equation IPSC=Q,N,ð1 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 SuccessesNp Þ to estimate themean quantal size (Q) and number of
releasesites (N) for eachsynapsepopulation.Solid lines indicatebestfit (black:WT,blue:R451CKI). Insetshows thedistributionof individualdatapoints.Mean±SEM.
(B) Computer simulations of PV basket cell IPSCs. Simulation results for WT (open black circles) and R451C KI (open blue circles) were not significantly different
(in mean IPSCs and successes) from their corresponding experimental IPSCs data sets when PR was set to 0.23 and 0.11, respectively, in the model (see main
text for further parameters).
(C) Light microscopy analysis of the bouton density of PV basket cell axons. Left: example of axonal segments for axons in WT and R451C KI mice.
Right: summary data from WT (n = 7) and R451C KI (n = 8) mice. p = 0.152, Mann-Whitney RST. Mean ± SEM.
(D) Bath application of m-opioid receptor antagonist CTAP (500 nM) in paired recording experiments between PV basket and pyramidal cells in R451C KI mice
(n = 4 pairs). Averaged time course (left) and time averaged means (right) of the four recordings did not show statistically significant effect of m-opioid receptor
antagonist on IPSCs. Mean ± SEM.
(E) Bath application of M2 muscarinic-receptor antagonist AF-DX 116 (10 mM) in paired recording experiments between PV basket and pyramidal cells in R451C
KI mice (n = 4 pairs). Averaged time course (left) and time averaged means (right) of the four recordings did not show statistically significant effect of m-opioid
receptor antagonist on IPSCs. Averaged data presented as mean ± SEM.
See also Figures S2 and S3.
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observed a small increase in IPSC half-width (Figure 4C;
WT: 4.9 ± 0.1 ms, NL3 KO: 5.6 ± 0.2) but no change in the size
of unitary minimal IPSCs (Figure 4D; WT: 25.3 ± 1.7 pA, NL3
KO: 29 ± 2.9 pA), or in the rate of finding synaptically connected
pairs of neurons (Figure 4E; WT: 2 ± 0.2, NL3 KO: 1.8 ± 0.2). The
fact that increased synaptic transmission at CCK basket cell
synapses is equally observed in NL3 KO and R451C KI neurons
shows that it is caused by a loss-of-function mechanism.
NL3 R451C KI Lowers the Probability of GABA Release
at PV Basket Cell Synapses
The change in success rates in our paired recordings of synap-
ses with the NL3 R451C KI or the NL3 KO mutations suggests
a presynaptic origin for the observed phenotypes, despite the
postsynaptic localization of NL3 (Budreck and Scheiffele,
2007). To evaluate whether presynaptic changes alone (such
as in the probability of release) could in principle account for
the NL3 related phenotypes, we analyzed these phenotypes by
modeling and computer simulations.502 Neuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc.We first plotted bin-averaged PV basket cell IPSC amplitudes
against their corresponding averaged success rates (Figure 5A;
inset shows distribution of individual pairs). We then fitted these
data with an equation that relates IPSC amplitudes to the suc-
cess rate of transmission (IPSC=Q,N,ð1 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 SuccessesNp Þ;
see Experimental Procedures and Figures S2A–S2C) to estimate
characteristic mean quantal size (Q) and number of release sites
(N) for WT (n = 25) and R451C KI (n = 26) populations. The result-
ing estimates for Q were similar for both genotypes (mean and
95% confidence intervals: 21.9/12.5–31.3 pA and 17.5/16.4–
18.6 pA for WT and R451C, respectively), as were the estimates
for N (mean and 95% confidence intervals: 7.6/1.6–13.6 and 8.7/
0–17.4 for WT and R451C synapses, respectively). These esti-
mates support the notion that the synaptic phenotype in R451C
mutant PV basket cell synapses was not due to a decrease in
quantal size (see Figure 1D) and, limited by the wide confidence
interval of estimates, also suggest that the R451C phenotype
was not due to a decrease in the number of release sites.
To examine the remaining possibility, namely that a lower neu-
rotransmitter release probability (PR) underlies the R451C
Neuron
Neuroligin-3 in Tonic Endocannabinoid Signalingphenotype, we performed computer simulations in which we
modeled IPSCs at different PR values (Figures 5B and S3). In this
computational model, we incorporated a minimal set of synaptic
parameters that allowed us to simulate the IPSC amplitudes and
success rates, and to compare these parameters to the experi-
mental data. The simulation parameters included, in addition to
the number of release sites (N), the mean and the variance of the
release probability (PR and sPR) and the mean and the variance
of the quantal amplitude (Q and sQ). For each simulated paired
recording, the computationally determined IPSC (cIPSC) was
derived as cIPSC=
PN
i =1pi,qi, and the computationally deter-
mined success rate (cSuccesses) was derived as cSuccess=
½1QNi =1ð1 piÞ,100, where pi and qi are the probability of
release and the quantal amplitude in the i-th release site, respec-
tively (see Experimental Procedures and Figures S3A–S3G).
We started the simulations by using Q and N values estimated
from the population quantal analysis (Figure 5A; see above) to
derive values for PR, sPR, and sQ that result in cIPSCs and
cSuccesses which approximate the experimentally determined
IPSCs and success rates. For PV basket cell IPSCs in WT neu-
rons, we found that a PR = 0.23, together with a sPR = 0.224
and a sQ = 2.25 (Q = 21 pA and N = 7, per modeling), provided
computationally determined cIPSCs and cSuccesses that did
not significantly differ from the experimental data (mean
difference ± SD for IPSCs: 0 ± 6 pA; for success rates: 0 ±
0.02; t test, p > 0.5 for both). For computer simulation of
R451C synapses, we found that much lowered release probabil-
ities, PR = 0.11, together with a sPR = 0.09 and a sQ = 1.65
(Q = 17 pA and N = 8, per modeling) were needed to replicate
the experimental data (mean difference ± SD for IPSCs: 0 ±
0.99 pA; for success rates: 0 ± 0.01; t test, p > 0.5 for both).
These simulations thus suggest that an 2-fold decrease in
the probability of GABA release could sufficiently explain the
NL3R451CKI phenotype in PV basket cell synapses. These con-
clusions were further supported by consequent analysis of bio-
cytin-filled axons (Figure 5C), which also did not indicate a differ-
ence in the number of synapses formed by individual PV basket
cells (WT: 0.33 ± 0.03 and R451C: 0.26 ± 0.01, synapses per mm,
Mann-Whitney RST, p = 0.152).
Next, we sought to determine a cause for lower release rates in
PV basket cell synapses in the R451C KI mice. We reasoned that
such decreases in release rate could be caused by NL3 muta-
tion-driven alterations of the presynaptic release machinery, or
alternatively, by overactivation of a presynaptic receptor, such
as a neuropeptide receptor, that physiologically suppresses
GABA release from these synapses (Freund and Katona,
2007).We addressed this latter possibility by application of phar-
macological agents in paired recording experiments.
Activation of two presynaptic G protein-coupled receptors,
namely m-opioid and M2 muscarinic-receptors, is known to sup-
press GABA release at PV basket cell synapses (Glickfeld et al.,
2008; Szabo´ et al., 2010). Thus, we tested the effect of the
m-opioid receptor antagonist CTAP (500 nM; Figure 5D; n = 4
pairs) and of the M2 muscarinic-receptor antagonist AF-DX
(10 mM; Figure 5E; n = 4 pairs) in paired-recordings of PV basket
cell to pyramidal neuron synapses in NL3R451CKImice. Neither
antagonist increased IPSC amplitudes in paired recordings, indi-
cating that tonic activation of these receptors does not accountfor the decreased transmission at PV basket cell synapses in
R451C KI mice. In additional control experiments, both antago-
nists reliably reversed the effect of their corresponding agonists,
DAMGO (1 mM) and carbachol (5 mM; not shown). Thus, the pres-
ence of NL3 the R451C mutation likely induces a functional
change in the presynaptic release properties of PV basket cell
synapses.
Neuroligin-3 Is Essential for Tonic Endocannabinoid
Signaling at CCK Basket Cell Synapses
Our data suggest that a loss of NL3 function produces an in-
crease in GABA release at synapses formed by CCK basket cells
onto pyramidal neurons synapses. CCK basket cell synapses
exhibit a distinct feature that offers an immediate hypothesis to
account for the observed phenotype. This feature consists of
the efficient suppression of GABA release from CCK basket
cell terminals by the endocannabinoid-mediated activation of
presynaptic CB1 receptors (reviewed in Alger, 2002; Piomelli,
2003; Freund and Katona, 2007).
Endocannabinoids are secreted from postsynaptic pyramidal
neurons to activate presynaptic CB1 receptors in two principal
modes. Phasic secretion of endocannabinoids is induced by
postsynaptic depolarization and/ormGluR5 activation andmedi-
ates decreases in synaptic transmission during short- and long-
term plasticity. Tonic secretion of endocannabinoids affects syn-
aptic transmission over longer time periods (reviewed in Alger,
2012; Katona and Freund, 2012). A deficiency in tonic endocan-
nabinoid signaling, with or without an effect on phasic endocan-
nabinoid signaling, would be expected to enhance the probability
of GABA release, and thus would increase IPSCs similar to what
we observed in R451C KI and NL3 KO neurons. Thus, we tested
the hypothesis that a loss of function of NL3—either via the KO or
via the R451C KI—impairs tonic endocannabinoid signaling.
In wild-type synapses, bath application of 10 mM AM251 (a
CB1 receptor antagonist and inverse agonist) caused an
100% increase in IPSC amplitudes and50% increase in suc-
cess rate (Figures 6A and 6B; 1 Hz AP firing), reflecting disinhibi-
tion of GABA release by blocking tonically active CB1 receptors
(Neu et al., 2007). In NL3 KO synapses, strikingly, AM251 did not
enhance IPSC amplitudes (Figures 6A, S4A, and S4B) or success
rates of synaptic transmission (Figures 6B, S4A, and S4B). These
findings suggest that IPSC amplitudes in the NL3 KOwere larger
because these synapses express higher release probabilities
due to an apparent lack of tonic CB1 receptor activation.
To evaluate whether differences in the release probability
alone, without other possible consequences of NL3 deletion,
could explain the observed phenotype, we again used modeling
and computer simulations. Fitting of the bin-averaged IPSC—
successes data (Figures 6C and S3A–S3C) resulted in similar
Q and N estimates for the NL3 WT and KO data sets (mean
and 95% confidence intervals; Q: 39 / 30.8-47.3 and 46.2 /
14.1-78.4 pA, and N: 5.6 / 4.1-7 and 4.4 / 2.9-11.8, for WT
and NL3 KO, respectively). Using these parameter estimates in
subsequent simulations (Figures 6D and S3A–S3G), we found
that the mean values of simulated IPSC–successes distributions
were not significantly different from experimental values (inset in
left panel) when PR = 0.12 (together with a sPR = 0.19 and a
sQ = 2; Q = 39 pA and n = 6 per model estimates) for NL3 WT,Neuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc. 503
Figure 6. Neuroligin-3 KO and R451C KI Mutations Impair Tonic Endocannabinoid Signaling
(A) Representative paired recordings (upper traces) and normalized time courses (lower left panel) demonstrate that bath application of 10 mM AM251 enhances
IPSCs in WT, but not in NL3 KOmice. Lower right panel: IPSC changes (failures included) in each paired-recording experiment (control: average data for minutes
1–5; AM251: for minutes 6–10; nWT = 9, p = 0.004; nNL3KO = 11, p = 0.268, paired t test). Mean ± SEM.
(B) Left panel: time courses of AM251 wash-in suggest that the lack of effect of AM251 on IPSCs was due to the failure of AM251 in increasing the number of
successful transmissions. Right panel: AM251 reliably increased the number of successes inWT, but not in NL3 KOmice (nWT = 9, p < 0.001; nNL3KO = 11, p = 0.79,
paired t test). Mean ± SEM.
(C) AveragedCCKbasket cell IPSCs (samedata as in Figure 4) are plotted against their corresponding averaged success rates (WTdatawerepooled fromwild-type
littermatesof R451CKI andNL3KOmice). Datawere fitted to theequation IPSC=Q,N,ð1 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 SuccessesNp Þ to estimate themeanquantal size (Q) andnumberof
releasesites (N) for eachsynapsepopulation.Solid lines indicatebest fit (black:WT, red:NL3KO). Inset shows thedistributionof individualdatapoints.Mean±SEM.
(D) Computer simulations of CCK basket cell IPSCs. Simulation results for WT (open black circles) and NL3 KO (open red circles) were not significantly different (in
mean IPSCs and successes) from their corresponding experimental IPSCs data sets when PR was set to 0.26 and 0.12, respectively, in the model (see main text
for further parameters).
(legend continued on next page)
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Neuroligin-3 in Tonic Endocannabinoid Signalingand when PR = 0.26 (together with a sPR = 0.26 and a sQ = 2.1;
Q = 46.2 pA and n = 5 per model estimates) for NL3 KO. In addi-
tion, we quantified axonal bouton densities (Figure 6E), which
were not different between the two genotypes (WT: 0.18 ± 0.01
and NL3 KO: 0.18 ± 0.01, per mm, t test, p = 0.779). Together,
these analyses suggest that the loss of tonic CB1 receptor acti-
vation, and the consequent2-fold increase in the probability of
GABA release, is sufficient to account for the entire phenotype of
the NL3 deletion at these synapses.
We next determined whether the loss of tonic CB1 receptor
activation was affecting GABA release only from basket cell syn-
apses, or whether all CB1-containing GABAergic synapses exhi-
bit this phenotype. Thus, we repeated the CB1 receptor blocking
experiments by monitoring IPSCs evoked by extracellular stimu-
lation (which will cause GABA release from a broad set of pre-
synaptic fibers that include CB1-receptor-containing axons).
Application of AM251 again enhanced IPSCs in CA1 pyramidal
cells, but consistently failed to do so in the NL3 KO (Figure 6F).
We also repeated these latter extracellular stimulation experi-
ments with CP 945,598, a CB1 receptor antagonist that is struc-
turally unrelated toAM251. Bath application of CP945,598 (5 mM)
replicated the findings with AM251 (Figure 6G), independently
confirming the absence of tonic EC signaling in NL3 KO mice.
Similar to the NL3 KO, paired recordings from slices prepared
from the NL3R451CKImice revealed that the effect of AM251 on
CCK basket cell IPSCs was greatly reduced (Figures 6H and 6I).
These data suggest that NL3 is essential for the tonic endocan-
nabinoid signaling that inhibits GABA release from CCK basket
cell synapses. Furthermore, we tested whether the NL3 KO
may alter tonic CB1 receptor-mediated signaling at glutamater-
gic synapses. We stimulated Schaffer-collateral synapses and
recorded from CA1 pyramidal cells (in the presence of 50 mM
picrotoxin). However, bath application of AM251 (10 mM) failed
to increase EPSC amplitudes in eitherWT slices or NL3 KO slices
(Figure 6J; see also Hoffman et al., 2010). Together, these data
suggest that NL3-related mutations may impair tonic endocan-
nabinoid signaling at CB1 receptor-containing inhibitory, but
not excitatory synapses.
NL3 Is Not Required for Phasic Endocannabinoid
Signaling
A loss of tonic endocannabinoid signaling could be due to a
specific ablation of tonic endocannabinoid secretion or to
a general block of all endocannabinoid secretion or endocanna-
binoid sensing, for example due to a removal of CB1 receptors.(E) Light microscopy analysis of the bouton density of CCK basket cell axon
Right: summary data from WT (n = 6) and NL3 KO (n = 7) mice. p = 0.779, t test.
(F) Time course of the effect of the AM251 wash-in on extracellularly evoked IPSC
increase in eIPSC amplitude in WT, but not in NL3 KO mice (Vpyramidal = 70 mV
p = 0.008; nNL3KO = 10, p = 0.63, paired t test). Mean ± SEM.
(G) Time course of the effect of the CP945598 wash-in on extracellularly evoked
show increase in eIPSC amplitude inWT, but not in NL3 KOmice (Vpyramidal =70m
p = 0.0005; nNL3KO = 18, p = 0.41, paired t test). Mean ± SEM.
(H and I) Paired recordings of IPSC amplitudes and success rates in response to
Right panels: absolute changes in each pair (nWT = 6, p = 0.07; nR451C = 10, p =
(J) Time-course of the effect of 10mMAM251wash-in onextracellularly evokedEPS
and NL3 KOmice (Vpyramidal =70 mV, 1 Hz stimulation, in the presence of 50 mM
See also Figures S2, S3 and S4.To differentiate between these possibilities, we examined phasic
endocannabinoid signaling in NL3 KO mice. We first analyzed
depolarization-induced suppression of inhibition (DSI). During
DSI, depolarization of pyramidal neurons induces transient
release of endocannabinoids, which retrogradely activate CB1
receptors, leading to powerful blockade of GABA release that
can last for several seconds (Pitler and Alger, 1994; Wilson and
Nicoll, 2001; Fo¨ldy et al., 2006). These experiments showed
that the NL3 KO did not affect the magnitude or time course of
DSI, documenting that CB1 receptors were properly localized
and phasic endocannabinoid signaling was retained in NL3 KO
mice (Figure 7A). We also tested whether the NL3 KO alters
the phasic endocannabinoid signaling that induces a long-term
depression of inhibitory synapses (I-LTD; Chevaleyre and Cas-
tillo, 2003; reviewed in Castillo et al., 2011). High-frequency
extracellular stimulation at the border of strata pyramidale and
radiatum reliably induced I-LTD both in wild-type and in NL3
KO mice (Figure 7B). Thus, the NL3 KO does not block two
different forms of synaptic plasticity dependent on phasic endo-
cannabinoid signaling.
DISCUSSION
In the present study, we systematically compared the synaptic
effects of two different mutations in NL3 that are associated
with autism, and examined in paired recordings inhibitory synap-
ses that are formed by two classes of presynaptic basket cells
onto the same class of postsynaptic pyramidal neurons in the
hippocampus.
This study had two goals. The first goal was based on the lack
of a common phenotype produced by the two NL3 mutations in
mice, despite their shared association with autism in humans,
prompting us to search for such a common phenotype. As a
starting point in this search, we used the altered rate of sponta-
neous mini activity that we had previously identified in NL3 KO
mice (Etherton et al., 2011a). We were led in this search by the
notion that the lack of a similar phenotype in R451C mutant
synapses could have been due to confounding gain-of-function
effects of the R451C substitution on other subsets of synapses
in the same neuron, which may have occluded a common
phenotype shared by the R451C KI and NL3 KO neurons.
Thus, to search for common phenotypes, we used paired
recordings which enabled us to separately monitor defined syn-
apses originating from two different classes of inhibitory basket
cells in the hippocampus.s. Left: example of axonal segments for axons in WT and NL3 KO mice.
Mean ± SEM.
s (eIPSC; left panel) and averaged data in each experiment (right panel) show
, 1 Hz stimulation, in the presence of 5 mM NBQX and 10 mM D-AP5; nWT = 6,
IPSCs (eIPSC; left panel), and averaged data in each experiment (right panel)
V, 1 Hz stimulation, in the presence of 5 mMNBQX and 10 mMD-AP5; nWT = 15,
10 mM AM251 in R451C KI mice. Left panels: time-course of the experiments.
0.072, paired t test). Mean ± SEM.
Cs (eEPSC; left panel) and averageddata in each experiment (right panel) inWT
picrotoxin; nWT = 11, p > 0.05; nNL3KO = 8, p > 0.05, paired t test). Mean ± SEM.
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Figure 7. Neuroligin-3 Is Not Required for Phasic Short-Term Endo-
cannabinoid Signaling (DSI) or Long-Term Endocannabinoid-
Dependent Synaptic Plasticity (i-LTD)
(A) Paired recordings show that DSI induced by phasic endocannabinoid
signaling was unaffected in NL3 KO (left panel: example of DSI, note the
transient suppression of IPSCs after brief depolarization in the pyramidal cell;
right panel: averaged time-course of DSI in WT and NL3 KO). Mean ± SEM.
(B) Deletion of NL3 does not affect the magnitude or time-course of the en-
docannabinoid-dependent I-LTD (Vpyramidal = +10 mV, interstimulus interval
20 s, [Clpipette] = 4 mM, in presence of 5 mM NBQX and 10 mM D-AP5).
Mean ± SEM.
Figure 8. Schematic Summary Diagram of the Effects of the NL3 KO
and R451C Substitution on Three Different Synapses on Pyramidal
Neurons in the CA1 Region of the Hippocampus
The diagram depicts a pyramidal neuron (green) receiving inputs from Schaffer
collateral fibers and two different types of basket cell neurons (PV, parvalbu-
min; CCK, cholecystokinin). The changes observed in NL3 R451C knockin and
KO mice are described on the left.
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Neuroligin-3 in Tonic Endocannabinoid SignalingThe second goal of this study was stimulated by our earlier re-
sults demonstrating that the R451C substitution produced
different synaptic phenotypes in distinct brain regions (Tabuchi
et al., 2007; Etherton et al., 2011a). These results led us to test
whether the NL3 KO and the R451C KI mutations might produce
different phenotypes even in distinct synapses formed onto the
same postsynaptic neuron. The differences in NL3 phenotypes
in different brain regions supported the hypothesis that NL3
does not simply act in establishing synapses as such, but func-
tions to specify synaptic properties depending on the presynap-
tic partner, a hypothesis that would predict that synapses
formed by different presynaptic partners on the same postsyn-
aptic neuron may also exhibit distinct changes in NL3 mutants.
Our study addresses both goals. The results suggest three
major conclusions that have implications not only for autism
pathophysiology, but also for synapse formation and synaptic
endocannabinoid signaling.
First, we unexpectedly found that NL3 is essential for tonic but
not phasic endocannabinoid signaling. The mechanisms of tonic
endocannabinoid signaling are not well studied—in fact, its very
existence as a specific process was unclear (Kim and Alger,
2010; Alger, 2012). Our finding that tonic endocannabinoid
signaling is impaired in NL3 KO neurons (and R451C KI neurons)506 Neuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc.validates this form of endocannabinoid signaling as a specific
regulatory process that is not an ‘‘accident’’ of endocannabinoid
leakage or spillover and identifies NL3 as the only protein known
to be specifically required for tonic endocannabinoid secretion.
The loss of tonic endocannabinoid signaling is the likely cause
for the change in mini event frequency we previously observed
in NL3 KOmice (Etherton et al., 2011a). The fact that this pheno-
type is caused by both the NL3 KO and the R451C KI suggests
that a loss of tonic endocannabinoid signaling may be a compo-
nent of autism pathogenesis and suggests new avenues for po-
tential treatments (Cravatt and Lichtman, 2003; Piomelli, 2003;
Katona and Freund, 2008). Although the mechanism by which
NL3 acts in tonic endocannabinoid secretion is unknown, it
seems likely that NL3 serves to localize the as yet unknown tonic
secretory machinery to synapses via trans-synaptic interactions
with neurexins. Alternatively, it is conceivable that the NL3 loss of
function activates an enzyme that selectively degrades ligands
of tonic but not the phasic endocannabinoid signal (Alger and
Kim, 2011; Alger, 2012).
Second, the R451C mutation causes both gain- and loss-of-
function effects (Figure 8). We previously demonstrated that the
R451C KI causes gain-of-function effects when we compared
the phenotype of the NL3 KO and R451C KI mutations in inhib-
itory synapses in the cortex and excitatory synapses in the
hippocampus (Tabuchi et al., 2007; Etherton et al., 2011a). In
these synapses, the NL3 KO elicited no major phenotype while
the NL3 R451C KI produced specific increases in synaptic
transmission. However, R451C loss-of-function effects were
not detected in earlier studies, although they are consistent
with the fact that the R451C mutation destabilizes NL3 and
reduces its levels by 90% (De Jaco et al., 2010; Tabuchi
et al., 2007). The present paper now shows that the R451C
mutation does indeed also cause loss-of-function phenotypes,
thereby reconciling the observation of both this mutation and
a NL3 deletion in autism (Jamain et al., 2003; Sanders et al.,
2011).
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Neuroligin-3 in Tonic Endocannabinoid SignalingThird, the R451C mutation causes distinct effects on different
types of synapses of the same postsynaptic neuron (Figure 8).
The differences between phenotypes induced by the R451C KI
suggests that NL3 acts in a context-dependent manner not
only in a regional sense (i.e., it has a different phenotype in
cortical versus hippocampal synapses), but also within a brain
region. This observation argues against what might be called a
‘‘mechanical’’ view of synaptic cell adhesionwhereby amolecule
performs the same function in all contexts—instead, the obser-
vations on the R451C mutation reveal that NL3 can perform
distinct functions, presumably depending on the ligands that
are available in a given synapse, a result that is consistent with
previous results obtained for neuroligin-2 (Gibson et al., 2009).
Moreover, the inhibition of PV-containing synapses by the
R451C substitution represents the first time the R451C mutation
was found to decrease synaptic strength as in previous studies it
always increased synaptic strength (Tabuchi et al., 2007; Ether-
ton et al., 2011a). The powerful size of this effect is again consis-
tent with a major regulatory function of neuroligins in synapses.
The multitude of the effects of the R451C mutation on neuro-
transmission (Figure 8) is surprising and supports the notion
that neuroligins participate in a balanced array of diverse func-
tions, possibly via interactions with multiple ligands. Specifically,
the R451C mutation may act by shifting the activity of NL3 in a
fluid interaction network composed of multiple competing
trans-synaptic ligands. Our previous studies suggested that at
least neuroligin-1 functions as a trans-synaptic cell-adhesion
molecule by binding both to neurexins and to as yet unidentified
other ligands (Ko et al., 2009). It is possible that the R451C mu-
tation blocks the binding of NL3 to one of the ligands, and/or
activates the binding of another ligand, thereby shifting the inter-
action network.
Although we show here that NL3 is selectively essential for
tonic endocannabinoid signaling, this result does not exclude
the possibility that NL3 performs other functions. In fact, analo-
gous to other genes such as RIMs (Kaeser et al., 2012), NL3
could perform additional major functions that are redundantly
also performed by other neuroligins. The previous analysis of
constitutive neuroligin triple KO mice strongly supports this
notion by revealing functional redundancy among neuroligins
(Varoqueaux et al., 2006), as does the observation of multiple
strong phenotypes produced by the R451C and R704C KI muta-
tions in NL3 (Tabuchi et al., 2007; Etherton et al., 2011a, 2011b).
The requirement for NL3 in tonic endocannabinoid signaling af-
firms the notion that neuroligins specify synapse properties, as
NL3 confers onto CCK-containing synapses tonic endocannabi-
noid signaling without influencing phasic signaling or other syn-
aptic parameters. Tonic endocannabinoid signaling was not pre-
viously associated with a specific regulatory mechanism but the
link to NL3 revealed here validates the importance of this
signaling pathway and suggests a possible endocannabinoid
involvement in autism.
EXPERIMENTAL PROCEDURES
Mouse Breeding and Genotyping
Mice were genotyped as described previously (Tabuchi et al., 2007; Etherton
et al., 2011a). All animal protocols and husbandry practices were approved by
the Institutional Animal Care and Use Committee at Stanford University.Electrophysiology
Hippocampal slices (300 mm)were prepared from 3–4weeks old NL3R451CKI
and NL3 KO mice. Slices were incubated at 33C in sucrose-containing artifi-
cial cerebrospinal fluid (ACSF; 85 mM NaCl, 75 mM sucrose, 2.5 mM KCl,
25 mM glucose, 1.25 mM NaH2PO4, 4 mM MgCl2, 0.5 mM CaCl2 and
24 mM NaHCO3) for an hour and then incubated in the same solution at
room temperature until recording. Electrophysiological recordings were
made in ACSF containing 126 mM NaCl, 2.5 mM KCl, 10 mM glucose,
1.25 mM NaH2PO4, 2 mM MgCl2, 2 mM CaCl2, and 26 mM NaHCO3. Slices
were visualized in an upright microscope (Olympus, BX-61WI) with infrared dif-
ferential interference contrast optics. Whole-cell recordings were obtained
from the interneurons with patch pipettes (King Precision Glass, Inc., 3–5
MU) filled with internal solution containing 126 mM K-gluconate, 4 mM KCl,
10 mM HEPES, 4 mM Mg-ATP, 0.3 Na-GTP, 10 mM phosphocreatine, and
0.2%biocytin (pH 7.2, 270–290mOsm), and from postsynaptic pyramidal cells
containing 40 mM CsCl, 90 mM K-gluconate, 1.8 mM NaCl, 1.7 mM MgCl2,
3.5 mM KCl, 0.05 mM EGTA, 10 mM HEPES, 2 mM Mg-ATP, 0.4 mM Na-
GTP, 10 mM phosphocreatine (pH 7.2, 270–290 mOsm; in some of the record-
ings 0.2% biocytin was also added to this solution). All electrophysiological
recordings were made at 33C, using MultiClamp700B amplifiers (Molecular
Devices, Sunnyvale, CA). Signals were filtered at 4 kHz using Bessel filter
and digitized at 10 kHz with a Digidata 1440A analog-digital interface (Molec-
ular Devices). Series resistance was monitored, and recordings were dis-
carded if the series resistance changed significantly or reached 25MU. The re-
corded traces were analyzed using Clampfit software (Molecular Devices). PV
and CCK interneurons were distinguished based on their distinct electrophys-
iological spiking properties (Fo¨ldy et al., 2010) and by the presence of DSI in
CCK basket cell synapses (see Figure 7A). IPSCs were individually inspected
and included in the analysis based on their onset latency following the presyn-
aptic action potential. For statistical analysis Student’s t test, paired t test or
Mann-Whitney rank-sum test (RST) was used, and data are presented as
mean ± SEM, unless noted otherwise; significance was p < 0.05.
Quantal Model
Individual basket cells innervate postsynaptic pyramidal cells via multiple
release sites (N; Biro´ et al., 2006; Fo¨ldy et al., 2010), in which intrinsically var-
iable synaptic parameters (such as quantal size and release probability; Q and
PR respectively) produce a trial-to-trial fluctuation in the IPSC amplitudes. The
distribution of these fluctuations can be described by models that are based
on binomial statistics and allow estimates of Q and N (Silver, 2003; Biro´
et al., 2006). In this study, we ought to extend quantal modeling to analyze
pooled data from multiple paired-recording experiments of defined synapse
populations, and extract mean quantal information that is characteristic to
each population. For modeling, we analyzed synapses by quantifying IPSC
amplitudes and success rates. Assuming that each synapse population can
be described by characteristic mean N and Q values, it is reasonable to as-
sume that the pair-to-pair variability in IPSC amplitudes and success rates is
dominated by variability in PR. In this case, the distribution of IPSC amplitudes
and success rates should follow the IPSC=Q,N,ð1 ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ1 SuccessesNp Þ
model (see Figure S2 for more information). For fitting the IPSC model on
experimental data, to estimate quantal parameters, we employed the built-
in, unconstrained NonlinearModelFit algorithm in Mathematica 8 (Wolfram
Research, Inc., Champaign, IL). Note that the basic assumptions of this
approach (i.e., the existence of characteristic Q and N values in each synapse
population) were supported by the similarity between the observed and pre-
dicted IPSC distributions (see Figures 5A and 6C).
Computational Model
In order to gain further qualitative insight into how pre- and postsynaptic
changes may contribute to the synaptic phenotypes produced by NL3 muta-
tions, we devised a simple computational model that incorporated five modifi-
able synaptic parameters: the number of release sites (N) and the mean and
variance of the release probability (PR and sPR, respectively) and of quantal
IPSCs (Q and sQ, respectively). Note that nonzero variances were necessary
to simulate variability both in the number of successful transmissions (by
sPR) and IPSC amplitudes (by sQ). To initialize the simulations, pi values (that
is the release probability of the i-th release site) were assigned randomlyNeuron 78, 498–509, May 8, 2013 ª2013 Elsevier Inc. 507
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for each release site. In addition, for each release site, qi values (that is the
quantal size in the i-th release site) were randomly assigned from a log-normal
probability distribution function of mean Q and sQ variance parameters (see
Figure S3 for more information). Computational IPSCs (cIPSCs) and suc-
cesses (cSuccesses) were derived as described in the text. For each condi-
tion, estimates of Q and N were adopted from the quantal model (Figures 5A
and 6C). Each simulation had the same sample size as the original data, and
each simulation was repeated 50 times with random assignments of new pi
and qi values. For statistical comparisons, we tested the null hypothesis that
the difference between the mean computed and experimental successes
and IPSCs were zero; simulation parameters were accepted when p > 0.05 us-
ing Student’s t test. To estimate the robustness of the resulting simulation pa-
rameters, we quantified an average range for each parameter which still jus-
tifies the null-hypothesis: DPR = ± 0.006, DsPR = ± 0.09, DQ = ± 0.7 pA and
DsQ = ± 0.06 pA (relative to values presented in the main text). Parameter de-
viations beyond these ranges independently resulted in statistically significant
differences (p  0.05) between the simulated and experimental distributions.
Simulations were implemented and run using Mathematica 8 (Wolfram
Research, Inc.).
Neuroanatomy
After recordings, all slices were transferred into a fixative solution containing
4%paraformaldehyde and 0.2%picric acid in 0.1M phosphate buffer. In order
to examine the axonal and dendritic arbor of presynaptic basket cell, biocytin-
filled cells were visualized after recordings with 3,3-diaminobenzidinetetrahy-
drochloride (0.015%) using PK-6100 DAB and Vectastain SK-4100 ABC kit
(Vector Laboratories, Burlingame, CA). Example basket cells in Figures 1
and 2 were reconstructed using Neurolucida 10 (MBF Bioscience). For axonal
bouton density quantification, axonal segments with corresponding boutons
were reconstructed using Neurolucida 10. The length of the axons (which aver-
aged 1180.4 ± 128.4 mm, mean length ± SEM, in the reconstructed cells) and
bouton numbers were determined using NeuroExplorer (MBF Bioscience).
SUPPLEMENTAL INFORMATION
Supplemental Information includes four figures and can be found with this
article online at http://dx.doi.org/10.1016/j.neuron.2013.02.036.
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